An Ascending Single-Dose Study of the Safety, Tolerability and Bioeffect of REGN1193

ClinicalTrials.gov ID: NCT01933763

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01933763. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study to assess the safety and tolerability of ascending single-doses of REGN1193 in healthy volunteers.

Study identification

NCT ID: NCT01933763
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Regeneron Pharmaceuticals; Industry
Enrollment: 56 participants

Conditions and interventions

Conditions

Healthy Volunteers

Interventions

REGN1193 Drug
Placebo Other

Drug · Other

Eligibility (public fields only)

Age range: 18 Years to 45 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 2013 (Type not available)
Primary completion: Jan 2015 (Actual)
Completion: Jan 2015 (Actual)
Last update posted: Mar 13, 2015

2013 – 2015

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Not listed	Dallas	Texas	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01933763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 13, 2015 · Synced Nov 15, 2026